JP2022552009A5 - - Google Patents
Info
- Publication number
- JP2022552009A5 JP2022552009A5 JP2022523031A JP2022523031A JP2022552009A5 JP 2022552009 A5 JP2022552009 A5 JP 2022552009A5 JP 2022523031 A JP2022523031 A JP 2022523031A JP 2022523031 A JP2022523031 A JP 2022523031A JP 2022552009 A5 JP2022552009 A5 JP 2022552009A5
- Authority
- JP
- Japan
- Prior art keywords
- lnp
- substituted
- composition
- group
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025185622A JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962923258P | 2019-10-18 | 2019-10-18 | |
| US62/923,258 | 2019-10-18 | ||
| PCT/US2020/056252 WO2021077066A1 (en) | 2019-10-18 | 2020-10-19 | Lipid and lipid nanoparticle formulation for drug delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025185622A Division JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022552009A JP2022552009A (ja) | 2022-12-14 |
| JP2022552009A5 true JP2022552009A5 (cg-RX-API-DMAC7.html) | 2023-10-23 |
Family
ID=75538682
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523031A Pending JP2022552009A (ja) | 2019-10-18 | 2020-10-19 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
| JP2025185622A Pending JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025185622A Pending JP2026012402A (ja) | 2019-10-18 | 2025-11-04 | 薬物送達のための脂質及び脂質ナノ粒子製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220396556A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4045020A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022552009A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220084365A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114828836A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020368556B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3155074A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021077066A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| CN113785975B (zh) * | 2021-09-09 | 2023-08-29 | 天津医科大学 | 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用 |
| AR128959A1 (es) * | 2022-04-04 | 2024-06-26 | Spark Therapeutics Inc | Mejora inmunológica del tratamiento del cáncer |
| WO2023196527A2 (en) * | 2022-04-08 | 2023-10-12 | SunVax mRNA Therapeutics Inc. | Ionizable lipid compounds and lipid nanoparticle compositions |
| WO2023230587A2 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| WO2024061354A1 (zh) * | 2022-09-23 | 2024-03-28 | 北京键凯科技股份有限公司 | 一种抑制top1基因表达的干扰rna及其应用 |
| CN118946544A (zh) * | 2023-03-09 | 2024-11-12 | 上海吉量医药工程有限公司 | 可离子化脂质分子及其制备方法和应用 |
| CN116082184B (zh) * | 2023-04-12 | 2023-06-30 | 山东大学 | 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用 |
| WO2025038494A1 (en) | 2023-08-11 | 2025-02-20 | Tune Therapeutics, Inc. | Compositions, systems, and methods for lymphoid cell differentiation using targeted gene activation |
| EP4777496A1 (en) * | 2023-09-11 | 2026-07-22 | The Trustees of The University of Pennsylvania | Compositions and methods for t cell targeted extrahepatic delivery of therapeutic agents |
| CN117482066B (zh) * | 2023-11-02 | 2024-08-13 | 深圳市易瑞生物技术股份有限公司 | 脂质组合物和用于脂质组合物的化合物 |
| WO2025209467A1 (en) * | 2024-04-01 | 2025-10-09 | Longuide Biopharma Corporation | Lipids and lipid nanoparticle formulations |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026161895A1 (en) | 2025-01-27 | 2026-07-30 | Tune Therapeutics, Inc. | Compositions, systems, and methods for epigenetic regulation of lipoprotein a (lpa) gene expression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009303345B2 (en) * | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| WO2010053572A2 (en) * | 2008-11-07 | 2010-05-14 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| US7635707B1 (en) * | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| WO2015011633A1 (en) * | 2013-07-23 | 2015-01-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for delivering messenger rna |
| WO2018081638A1 (en) * | 2016-10-27 | 2018-05-03 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified rna for inducing an adaptive immune response |
-
2020
- 2020-10-19 CA CA3155074A patent/CA3155074A1/en active Pending
- 2020-10-19 EP EP20877084.2A patent/EP4045020A4/en active Pending
- 2020-10-19 US US17/769,858 patent/US20220396556A1/en active Pending
- 2020-10-19 KR KR1020227016630A patent/KR20220084365A/ko not_active Ceased
- 2020-10-19 JP JP2022523031A patent/JP2022552009A/ja active Pending
- 2020-10-19 WO PCT/US2020/056252 patent/WO2021077066A1/en not_active Ceased
- 2020-10-19 AU AU2020368556A patent/AU2020368556B2/en active Active
- 2020-10-19 CN CN202080088019.XA patent/CN114828836A/zh active Pending
-
2025
- 2025-11-04 JP JP2025185622A patent/JP2026012402A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022552008A5 (cg-RX-API-DMAC7.html) | ||
| JP2026012402A5 (cg-RX-API-DMAC7.html) | ||
| AU2019345104B2 (en) | Therapeutic nanoparticles and methods of use thereof | |
| CN101291653B (zh) | 脂质包封的干扰rna | |
| US10626393B2 (en) | Delivering CRISPR therapeutics with lipid nanoparticles | |
| JP2021535226A5 (cg-RX-API-DMAC7.html) | ||
| US20180245074A1 (en) | Treating hepatitis b virus infection using crispr | |
| JP2024518375A5 (cg-RX-API-DMAC7.html) | ||
| JP2012509258A (ja) | 核酸送達系のための分岐カチオン性脂質 | |
| JP2011529912A (ja) | 核酸送達システム用のナノ粒子組成物 | |
| JP2012509272A (ja) | 核酸送達系のための放出性カチオン脂質 | |
| US20240115730A1 (en) | Tissue-specific nucleic acid delivery by 1,2-dioleoyl-3-trimethylammonium-propane (dotap) lipid nanoparticles | |
| JP2022552009A (ja) | 薬物送達のための脂質及び脂質ナノ粒子製剤 | |
| US20220265817A1 (en) | Therapeutic compositions and methods for treating hepatitis b | |
| JP2021526505A (ja) | 治療用タンパク質の標的細胞に特異的な産生のための、および、標的細胞に関連する疾患、疾病、または障害の処置のための、融合性脂質ナノ粒子、および、融合性脂質ナノ粒子の製造方法と使用方法 | |
| JP2025541727A (ja) | 新規のポリグリセロールコンジュゲート脂質及びそれを含む脂質ナノ粒子組成物 | |
| WO2019212288A1 (ko) | Messenger rna 전달용 고분자 나노입자 조성물 및 그 제조방법 | |
| CA3262393C (en) | Lipid composition targeting antigen-presenting cells and use thereof | |
| Lee et al. | Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor | |
| CN110022895A (zh) | 用于治疗乙型肝炎的治疗组合物和方法 | |
| US20240417738A1 (en) | Immunotherapies for the treatment of cancer | |
| JPWO2022244815A5 (cg-RX-API-DMAC7.html) | ||
| JP5299424B2 (ja) | 薬物担体 | |
| US10722599B2 (en) | Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies | |
| WO2025090663A1 (en) | Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same |